Literature DB >> 18551234

The dawning of a new age of toxicology.

Marcel Leist1, Thomas Hartung, Pierluigi Nicotera.   

Abstract

Toxicology faces enormous challenges in a world in which we are exposed to thousands of chemicals and millions of mixtures thereof. Radically new approaches to this problem need to be developed. A milestone in this direction is the vision of the US National Research Council (NRC) "Toxicity testing in the 21st century: a Vision and a Strategy". Currently, an alliance formed by the National Toxicology Program (NTP) and the Chemical Genomics Centre (NCGC) of the National Institutes of Health (NIH) and the Computational Toxicology Centre (NCCT) of the Environmental Protection Agency (EPA) is testing whether this new strategy can realistically form the basis of future public health decisions. The vision requires a radical paradigm shift in the approach to safety assessments, and turns the traditional procedures upside down. Where animal experiments used to be the most important technology, the future is seen in the strength of in vitro and in silico approaches based on human material. Today's toxicity testing starts with an initial black box screen on animals, sometimes followed by mechanistic studies, while the new vision approaches hazard assessment bottom-up. The procedure would begin with in vitro tests to define the affected pathways. To fill remaining gaps of knowledge, limited and targeted testing in animals would then be performed as a possible second step. This means nothing less than changing toxicology from being a predominantly observational craft and regulatory support discipline back to a natural science with all its dimensions. The background and the implications are discussed here in particular for a readership with interest also in parallel European trends.

Entities:  

Mesh:

Year:  2008        PMID: 18551234

Source DB:  PubMed          Journal:  ALTEX        ISSN: 1868-596X            Impact factor:   6.043


  29 in total

1.  Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing.

Authors:  B Zimmer; P B Kuegler; B Baudis; A Genewsky; V Tanavde; W Koh; B Tan; T Waldmann; S Kadereit; M Leist
Journal:  Cell Death Differ       Date:  2010-09-24       Impact factor: 15.828

Review 2.  Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities.

Authors:  Lena Smirnova; Helena T Hogberg; Marcel Leist; Thomas Hartung
Journal:  ALTEX       Date:  2014       Impact factor: 6.043

Review 3.  Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts.

Authors:  Christoph van Thriel; Remco H S Westerink; Christian Beste; Ambuja S Bale; Pamela J Lein; Marcel Leist
Journal:  Neurotoxicology       Date:  2011-10-12       Impact factor: 4.294

4.  Toxicology for the twenty-first century.

Authors:  Thomas Hartung
Journal:  Nature       Date:  2009-07-09       Impact factor: 49.962

5.  21st Century Cell Culture for 21st Century Toxicology.

Authors:  David Pamies; Thomas Hartung
Journal:  Chem Res Toxicol       Date:  2016-12-05       Impact factor: 3.739

6.  Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation.

Authors:  Vaibhav Shinde; Stefanie Klima; Perumal Srinivasan Sureshkumar; Kesavan Meganathan; Smita Jagtap; Eugen Rempel; Jörg Rahnenführer; Jan Georg Hengstler; Tanja Waldmann; Jürgen Hescheler; Marcel Leist; Agapios Sachinidis
Journal:  J Vis Exp       Date:  2015-06-17       Impact factor: 1.355

7.  Metabolomics in toxicology and preclinical research.

Authors:  Tzutzuy Ramirez; Mardas Daneshian; Hennicke Kamp; Frederic Y Bois; Malcolm R Clench; Muireann Coen; Beth Donley; Steven M Fischer; Drew R Ekman; Eric Fabian; Claude Guillou; Joachim Heuer; Helena T Hogberg; Harald Jungnickel; Hector C Keun; Gerhard Krennrich; Eckart Krupp; Andreas Luch; Fozia Noor; Erik Peter; Bjoern Riefke; Mark Seymour; Nigel Skinner; Lena Smirnova; Elwin Verheij; Silvia Wagner; Thomas Hartung; Bennard van Ravenzwaay; Marcel Leist
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

8.  Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach.

Authors:  Anne K Krug; Raivo Kolde; John A Gaspar; Eugen Rempel; Nina V Balmer; Kesavan Meganathan; Kinga Vojnits; Mathurin Baquié; Tanja Waldmann; Roberto Ensenat-Waser; Smita Jagtap; Richard M Evans; Stephanie Julien; Hedi Peterson; Dimitra Zagoura; Suzanne Kadereit; Daniel Gerhard; Isaia Sotiriadou; Michael Heke; Karthick Natarajan; Margit Henry; Johannes Winkler; Rosemarie Marchan; Luc Stoppini; Sieto Bosgra; Joost Westerhout; Miriam Verwei; Jaak Vilo; Andreas Kortenkamp; Jürgen Hescheler; Ludwig Hothorn; Susanne Bremer; Christoph van Thriel; Karl-Heinz Krause; Jan G Hengstler; Jörg Rahnenführer; Marcel Leist; Agapios Sachinidis
Journal:  Arch Toxicol       Date:  2012-11-21       Impact factor: 5.153

Review 9.  Perspectives on In Vitro to In Vivo Extrapolations.

Authors:  Thomas Hartung
Journal:  Appl In Vitro Toxicol       Date:  2018-12-08

Review 10.  State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.

Authors:  Natalie Alépée; Anthony Bahinski; Mardas Daneshian; Bart De Wever; Ellen Fritsche; Alan Goldberg; Jan Hansmann; Thomas Hartung; John Haycock; Helena Hogberg; Lisa Hoelting; Jens M Kelm; Suzanne Kadereit; Emily McVey; Robert Landsiedel; Marcel Leist; Marc Lübberstedt; Fozia Noor; Christian Pellevoisin; Dirk Petersohn; Uwe Pfannenbecker; Kerstin Reisinger; Tzutzuy Ramirez; Barbara Rothen-Rutishauser; Monika Schäfer-Korting; Katrin Zeilinger; Marie-Gabriele Zurich
Journal:  ALTEX       Date:  2014-07-14       Impact factor: 6.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.